Financials

News Ideas Discussions Technicals Forecast Seasonals

ALCAR fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Carmat SA is a medtech that designs, manufactures and markets the Aeson artificial heart. It focuses on Aeson to make the first alternative to a heart transplant, and thus provide a therapeutic solution for people suffering from end-stage biventricular heart failure. The company was founded by Pouletty Philippe and Alain Carpentier on June 25, 2008 and is headquartered in Vélizy Villacoublay, France.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

ALCAR has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company